Enriching Feeding Tube Nutrition may Increase Risk of Death for ICU Patients

Providing high protein nutrition diet through a feeding tube enriched with immune-modulating nutrients, such as glutamine, omega-3 fatty acids, and antioxidants, for mechanically ventilated patients in intensive care units (ICU) provides no significant benefit in avoiding new complications compared to standard high-protein nutrition with a new study published in JAMA suggesting that it may indeed be harmful as it increases the risk of death at six months. Several meta-analyses have reported that use of immune-modulating nutrients in enteral (via feeding tube) nutrition is associated with reductions in illness from infections and improved recovery from critical illness compared with standard enteral nutrition. However, there is a lack of consensus in guidelines regarding enteral administration of immune-modulating nutrients, according to background information in the article.

Arthur R. H. van Zanten, M.D., Ph.D., of the Gelderse Vallei Hospital, Ede, the Netherlands, and colleagues randomly assigned 301 adult ICU patients who were expected to be ventilated and to require enteral nutrition for more than 72 hours to either immune-modulating nutrients (IMHP) (n = 152) or high-protein enteral nutrition (HP) (n = 149). The patients were from 14 ICUs in the Netherlands, Germany, France, and Belgium. Patients were followed for up to six months.

The researchers found that there were no significant differences in the incidence of new infections between groups. Overall, 53 percent of those in the IMHP group vs 52 percent in the HP group had new infections. No significant differences were observed in outcomes such as mechanical ventilation duration, ICU and hospital lengths of stay, and a measure of organ failure. The 6-month mortality rate was higher in the medical subgroup: 54 percent in the IMHP group vs 35 percent in the HP group.

"These findings do not support the use of high-protein enteral nutrition enriched with immune-modulating nutrients in these patients," the authors conclude.

Editor's Note: Nutricia Advanced Medical Nutrition, Nutricia Research, Utrecht, the Netherlands was the study sponsor. Please see the article for additional information, including other authors, author contributions and affiliations, financial disclosures, etc.

Editorial: Immunonutrition in Critical Illness - Limited Benefit, Potential Harm

Advertisement

Diet Management in Acidity and GERD | Nutritional Management in Acidity
Do you suffer from GERD and acidity? Try out some very useful diet tips to reduce the problem and decrease your dependence on medication.

Todd W. Rice, M.D., M.Sc., of the Vanderbilt University School of Medicine, Nashville, Tenn., writes in an accompanying editorial that many questions surrounding immunonutrition remain unanswered.

"Are there specific critically ill populations that may benefit from some immunomodulation or supplementation of individual immunomodulating agents, such as glutamine supplementation in burns or vitamin D replacement in severe sepsis? Does administration of multiple potential immunologic modulating agents together alter the individual effects of each agent? Combined administration in a single formula or supplement in all of these trials prevents implicating any single component (i.e., omega-3 fatty acids, glutamine, or antioxidants). In addition, enteral and parenteral [intravenous] administration may result in differential effects. Although these uses of immunomodulating nutrition still need to be explored, the similarity of the results and the suggestion of harm from recently published, large, randomized trials of immunonutrition should strongly discourage intensivists from its routine prescription for critically ill patients in clinical practice outside the scope of well-designed randomized clinical trials."

Advertisement

Editor's Note: The author has completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest and none were reported.



Source-Eurekalert